Durable complete response with PANVAC and Trastuzumab in metastatic triple positive breast cancer (mTPBC)

被引：0
|
作者：
Gatti-Mays, Margaret [1 ]
Mohebtash, Mahsa [2 ]
Madan, Ravi [1 ]
Strauss, Julius [1 ]
Bilusic, Marijo [1 ]
Jochems, Caroline [1 ]
Rauckhorst, Myrna [1 ]
Jones, Elizabeth [3 ]
Dahut, William [1 ]
Schlom, Jeffrey [1 ]
Gulley, James [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] Medstar Union Mem Hosp, Baltimore, MD USA
[3] NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P440
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancer
    Gullo, G.
    Zuradelli, M.
    Sclafani, F.
    Santoro, A.
    Crown, J.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2204 - 2205
  • [2] Trastuzumab use in patients with durable complete response in HER2-amplified metastatic breast cancer: to continue or not to continue
    Butterbaugh, S. T.
    Patel, R.
    Romond, E. H.
    Mathew, A.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 3098 - 3099
  • [3] Response of metastatic breast cancer to trastuzumab?
    Barnes, DM
    Miles, DW
    LANCET, 2000, 355 (9199): : 160 - 161
  • [4] Complete and Durable Response to Tamoxifen and Ovarian Ablation in the Treatment of Metastatic Breast Cancer
    Abdel-Razeq, Hikmat
    Abunasser, Mahmoud
    Farfoura, Heba
    Abdel-Razeq, Rshid
    Khzouz, Jakub
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [5] Termination of trastuzumab-based treatment after complete response in HER2-positive metastatic breast cancer
    Dogan, Izzet
    Aydin, Esra
    Khanmammadov, Nijat
    Aydiner, Adnan
    Saip, Pinar
    CANCER RESEARCH, 2021, 81 (04)
  • [6] Very long response with trastuzumab for metastatic Her2-positive breast cancer
    Lai-Tiong, F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 1002 - 1003
  • [7] When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?
    Beda, Manuela
    Basso, Umberto
    Ghiotto, Cristina
    Monfardini, Silvio
    TUMORI JOURNAL, 2007, 93 (05): : 491 - 492
  • [8] DURABLE REMISSIONS WITH TRASTUZUMAB TREATMENT FOR HER2 POSITIVE METASTATIC BREAST CANCER - SINGLE CENTER EXPERIENCE
    Tomasevic, Zoran
    Tomasevic, Zorica
    Neric, Dobrica
    Milosevic, Snezana
    Ivana, Bozovic-Spasojevic
    Zdravko, Zdrale
    Sarcevic, Aleksandra
    Kolarevic, Daniela
    BREAST, 2015, 24 : S42 - S42
  • [9] Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer
    Park, Hyung Soon
    Sohn, Joohyuk
    Kim, Seung Il
    Park, Seho
    Park, Hyung Seok
    Gho, Seul Ghi
    Chung, Hyun Cheol
    Paik, Soonmyung
    Kim, Gun Min
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 255 - 262
  • [10] Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer
    Hyung Soon Park
    Joohyuk Sohn
    Seung Il Kim
    Seho Park
    Hyung Seok Park
    Seul Ghi Gho
    Hyun Cheol Chung
    Soonmyung Paik
    Gun Min Kim
    Breast Cancer Research and Treatment, 2017, 163 : 255 - 262
12345